# Towards Nova one advisor Full Content Index Canonical URL: https://www.novaoneadvisor.com/ ## Featured Research - [U.S. Anatomic Pathology Market](https://www.novaoneadvisor.com/report/us-anatomic-pathology-market) - The U.S. anatomic pathology market size is calculated at USD 11.11 billion in 2025, grow to USD 11.92 billion in 2026, and is projected to reach around USD 22.30 billion by 2035, growing at a CAGR of 7.22% from 2026 to 2035. The market is growing due to rising cancer prevalence and increasing demand for early and accurate disease diagnosis. Technological advancements in diagnostic tools are further boosting market expansion. - [U.S. Cell and Gene Therapy Clinical Trials Market](https://www.novaoneadvisor.com/report/us-cell-gene-therapy-clinical-trials-market) - The U.S. cell and gene therapy clinical trials market size is calculated at USD 5.92 billion in 2025, grows to USD 6.55 billion in 2026, and is projected to reach around USD 16.00 billion by 2035, growing at a CAGR of 10.45 from 2026 to 2035. The U.S. cell and gene therapy clinical trials market growth is driven by the rising burden of chronic diseases and genetic disorders, streamlined regulatory approval processes, and increasing emphasis on personalized medicine. - [U.S. Clinical Laboratory Services Market](https://www.novaoneadvisor.com/report/us-clinical-laboratory-services-market) - The U.S. clinical laboratory services market size is calculated at USD 10.35 billion in 2025, grows to USD 10.88 billion in 2026, and is projected to reach around USD 16.94 billion by 2035, expanding at a CAGR of 5.05% from 2026 to 2035. The U.S. clinical laboratory services market growth is driven by the rising chronic disease burden, increasing demand for diagnostic procedures and screening tests, and focus on preventive healthcare. - [CRISPR-based Gene Editing Market](https://www.novaoneadvisor.com/report/crispr-based-gene-editing-market) - The global CRISPR-based gene editing market size was valued at USD 7.25 billion in 2025 and is anticipated to reach around USD 28.77 billion by 2035, growing at a CAGR of 14.78% from 2026 to 2035. The growth of the CRISPR-based gene editing market is driven by increasing incidences of genetic disorders, continuous advancements in CRISPR technology, focus on personalized medicine and regenerative medicine as well as rising investments in CRISPR research and development. - [Nanotechnology Market](https://www.novaoneadvisor.com/report/nanotechnology-market) - The nanotechnology market size was exhibited at USD 9.15 billion in 2025 and is projected to hit around USD 163.30 billion by 2035, growing at a CAGR of 33.4% during the forecast period 2026 to 2035. The market is growing due to wide application in healthcare, electronics, energy, and materials, offering advanced solutions with higher efficiency. Increasing R&D investment and government support are further accelerating its adoption worldwide. - [RNA Therapeutics Market](https://www.novaoneadvisor.com/report/rna-therapeutics-market) - The global RNA therapeutics market was valued at USD 8.55 billion in 2025 and is projected to hit around USD 28.94 billion by 2035, growing at a CAGR of 12.97% during the forecast period 2026 to 2035. The growth of the market is attributed to the rising prevalence of chronic diseases, innovations in RNA technologies, and increasing investments in R&D. - [Biobanking Market](https://www.novaoneadvisor.com/report/biobanking-market) - The global biobanking market was valued at USD 87.75 billion in 2024 and is projected to hit around USD 213.53 billion by 2034, growing at a CAGR of 9.3% during the forecast period 2025 to 2034. The growth of the market is attributed to the increasing R&D spending, expanding biobanking networks, and ongoing advancements in sample collection and processing technologies. - [Immunofluorescence Assay Market](https://www.novaoneadvisor.com/report/immunofluorescence-assay-market) - The global immunofluorescence assay market was valued at USD 3.83 billion in 2025 and is projected to hit around USD 6.41 billion by 2035, growing at a CAGR of 5.28% during the forecast period 2026 to 2035. The growth of the market is driven by the rising prevalence of chronic diseases, ongoing technological advancements, and expanding scope of applications of immunofluorescence assays. Increasing investments in R&D further contribute to market expansion. - [Cell and Gene Therapy Market](https://www.novaoneadvisor.com/report/cell-and-gene-therapy-market) - The global cell and gene therapy market size was estimated at USD 26.35 billion in 2025 and is projected to hit around USD 146.31 billion by 2035, growing at a CAGR of 18.7% during the forecast period from 2026 to 2035. The market is driven by the rising prevalence of chronic disease, innovation in technology, such as gene editing technologies, vector delivery systems, and improved manufacturing and delivery technologies. - [Viral Vector and Plasmid DNA Manufacturing Market](https://www.novaoneadvisor.com/report/viral-vector-and-plasmid-dna-manufacturing-market) - The viral vector and plasmid DNA manufacturing market size was exhibited at USD 7.71 billion in 2025 and is projected to hit around USD 46.81 billion by 2035, growing at a CAGR of 19.76% during the forecast period 2026 to 2035. - [U.S. Generic Drugs Market](https://www.novaoneadvisor.com/report/us-generic-drug-market) - The U.S. generic drugs market size was estimated at USD 144.22 billion in 2025 and is projected to hit around USD 209.41 billion by 2035, expanding at a CAGR of 3.8% during the forecast period from 2026 to 2035. The rising prevalence of chronic diseases and increasing government funding in research and development activities in the generic drugs sector are expected to boost the expansion of the market in the coming years. - [Active Pharmaceutical Ingredients CDMO Market](https://www.novaoneadvisor.com/report/active-pharmaceutical-ingredients-cdmo-market) - The global active pharmaceutical ingredients CDMO market size was valued at USD 139.33 billion in 2025 and is anticipated to reach around USD 292.79 billion by 2035, growing at a CAGR of 7.71% from 2026 to 2035. - [Implantable Medical Devices Market ](https://www.novaoneadvisor.com/report/implantable-medical-devices-market) - The global implantable medical devices market size is calculated at USD 103.7 billion in 2025, grows to USD 110.23 billion in 2026, and is projected to reach around USD 189.92 billion by 2035, growing at a CAGR of 6.24% from 2026 to 2035. The implantable medical devices market growth is driven by the increasing demand for implants, rising regulatory approvals and innovative product launches. - [Single-use Bioprocessing Market](https://www.novaoneadvisor.com/report/single-use-bioprocessing-market) - The global single-use bioprocessing market size is calculated at USD 39.25 billion in 2025, grows to USD 45.64 billion in 2026, and is projected to reach around USD 177.53 billion by 2035. grow at a CAGR of 16.29% from 2026 to 2035. The market is growing due to rising demand for cost-efficient, flexible, and contamination-free biomanufacturing solutions. Increasing adoption in biologics and vaccine production further fuels its expansion. - [U.S. Single-use Bioprocessing Market](https://www.novaoneadvisor.com/report/us-single-use-bioprocessing-market) - The U.S. single-use bioprocessing market size is calculated at USD 12.66 billion in 2025, grows to USD 14.72 billion in 2026, and is projected to reach around USD 57.25 billion by 2035, grow at a CAGR of 16.29% from 2026 to 2035. The U.S. single-use bioprocessing market is expanding with the rising use of single-use bioreactors, growing demand for biopharmaceuticals and automation of bioprocessing technologies. - [Advanced Therapy Medicinal Products CDMO Market](https://www.novaoneadvisor.com/report/advanced-therapy-medicinal-products-cdmo-market) - The global advanced therapy medicinal products CDMO market size was estimated at USD 9.35 billion in 2025 and is projected to hit around USD 53.11 billion by 2035, growing at a CAGR of 18.97% during the forecast period from 2026 to 2035. - [AI In Healthcare Market ](https://www.novaoneadvisor.com/report/ai-in-healthcare-market) - The AI in healthcare market size was exhibited at USD 37.09 billion in 2025 and is projected to hit around USD 861.04 billion by 2035, growing at a CAGR of 36.95% during the forecast period 2026 to 2035. - [Viral Capsid Development Market](https://www.novaoneadvisor.com/report/viral-capsid-development-market) - The global viral capsid development market size was estimated at USD 314.25 million in 2025 and is expected to reach USD 840.63 million in 2035, expanding at a CAGR of 10.34% over the forecast period of 2026-2035. The market growth is driven by increased regulatory approvals for gene-based treatments, innovation in technological advancements in engineering, and rising demand for large-scale, cost-effective manufacturing, which has led to increased partnerships with CDMOS. - [Cell Therapy Human Raw Materials Market](https://www.novaoneadvisor.com/report/cell-therapy-human-raw-materials-market) - The global cell therapy human raw materials market size was estimated at USD 4.75 billion in 2025 and is expected to hit USD 25.76 billion in 2035, expanding at a CAGR of 18.42% over the forecast period of 2026-2035. The market growth is driven by rising demand for cell-based therapies, the industry is moving from autologous to allogeneic therapies, which requires higher volumes of raw materials, such as serum albumin drive growth, and significant investment for research and development. - [Scaffold-free 3D Cell Culture Market](https://www.novaoneadvisor.com/report/scaffold-free-3d-cell-culture-market) - The global scaffold-free 3D cell culture market was estimated at USD 344.35 million in 2025 and is projected to hit USD 882.66 million by 2035, growing at a CAGR of 9.87% over 2026-2035. The market growth is driven by the increasing demand for specialized cancer models to study diseases mechanism and test therapies, increased research funding, research and development in biotechnology, and advancement in cell culture technologies, and growing interest in personalized medicine. - [Effective Microorganisms Market](https://www.novaoneadvisor.com/report/effective-microorganisms-market) - The global effective microorganisms market was estimated at USD 383.55 million in 2025 and is projected to reach USD 904.68 million by 2035, growing at a CAGR of 8.96% over the forecast period 2026-2035. The market growth is driven by growing technological advancement producing new, more effective microbial formulations for varied agriculture needs, a shift away from chemical fertilizers and pesticides towards bio-based soil enhancers has spurred adoption, and environmental remediation and waste management. - [Platelet Rich Plasma Market](https://www.novaoneadvisor.com/report/platelet-rich-plasma-market) - The global platelet rich plasma market was estimated at USD 650.13 million in 2025 and is projected to reach USD 2,246.28 million by 2035, growing at a CAGR of 13.2% over the forecast period 2026-2035. Market growth is driven by rising demand for anti-aging solutions and hair restoration, which has created a surge in PRP demand; increasing injuries and chronic conditions; growing numbers of consumers and providers who prefer non-surgical alternatives to surgery; and rising awareness and high disposable incomes. - [Synthetic Gene Circuits Market](https://www.novaoneadvisor.com/report/synthetic-gene-circuits-market) - The global synthetic gene circuits market was estimated at USD 1.95 billion in 2025 and is projected to reach USD 7.54 billion by 2035, growing at a CAGR of 10.48% over the forecast period 2026-2035. Market growth is driven by advancement in the engineering of custom cells for targeted therapies, such as cancer immunotherapy, improving selectivity and reducing exhaustion, gene circuits are increasingly used to create complex cell-based assays, improving speed of drug hit trudge and evaluating therapeutic effects in organoids, and the rising high levels of funding for synthetic biology, particularly in Asia Pacific region are fostering rapid innovation. - [Lyophilization Equipment and Services Market](https://www.novaoneadvisor.com/report/lyophilization-equipment-and-services-market) - The global lyophilization equipment and services market was estimated at USD 5.55 billion in 2025 and is projected to reach USD 13.09 billion by 2035, growing at a CAGR of 8.96% over the forecast period 2026 to 2035. Market growth is driven by increasing prevalence of chronic diseases and the shift toward biologics and vaccines demand sophisticated freeze-drying to maintain potency, advancements in technology, modern equipment now features automated, energy-efficient designs, separate drying chambers to prevent cross-contamination, and real-time monitoring through IoT, and expanding outsourcing to CDMOs. - [U.S. AI In Spine Surgery Market](https://www.novaoneadvisor.com/report/us-ai-spine-surgery-market) - The U.S. AI in spine surgery market size was estimated at USD 243.68 million in 2025 and is projected to increase from USD 280.67 million in 2026 to approximately USD 1,001.36 million by 2035, growing at a CAGR of 15.18% from 2026 to 2035. The U.S. AI in spine surgery market is driven by the rising demand for minimally invasive procedures and the widespread adoption of robotic-assisted surgery systems, which integrate AI for improved accuracy and real-time guidance. and optimize hospital workflows and reduce the high costs associated with revision surgeries. - [Cell Therapy Monitoring Kits Market](https://www.novaoneadvisor.com/report/cell-therapy-monitoring-kits-market) - The cell therapy monitoring kits market size was estimated at USD 1.45 billion in 2025 and is projected to increase from USD 1.56 billion in 2026 to approximately USD 3.07 billion by 2035, growing at a CAGR of 7.8% from 2026 to 2035. The cell therapy monitoring kits market is driven by the rising prevalence of chronic diseases, expansion of CAR-T and cell-based therapies, and rise in complex autologous cell therapies, where cells are patient-derived, necessitates rigorous, personalized process control to manage variability. - [DNA Manufacturing Market](https://www.novaoneadvisor.com/report/dna-manufacturing-market) - The DNA manufacturing market size was estimated at USD 6.55 billion in 2025 and is projected to increase from USD 7.72 billion in 2026 to approximately USD 33.99 billion by 2035, growing at a CAGR of 17.9% from 2026 to 2035. The DNA manufacturing market is driven by the rise in gene therapy and advanced therapeutics, the expansion of mRNA vaccine technology, and growing investment in biopharma and synthetic biology. - [Surgical Sutures Market ](https://www.novaoneadvisor.com/report/surgical-sutures-market) - The surgical sutures market size was estimated at USD 5.35 billion in 2025 and is projected to increase from USD 5.62 billion in 2026 to approximately USD 8.70 billion by 2035, growing at a CAGR of 4.98% from 2026 to 2035. The surgical sutures market is driven by the increasing in conditions, such as cardiovascular disorders, cancer, and diabetes requires frequent surgical interventions, boosting the need for wound closure solutions, innovations in the technology, and growing disposable income in the region. - [Aesthetic Injectable Market](https://www.novaoneadvisor.com/report/aesthetic-injectable-market) - The aesthetic injectable market size was estimated at USD 11.35 billion in 2025 and is projected to increase from USD 12.51 billion in 2026 to approximately USD 29.98 billion by 2035, growing at a CAGR of 10.2% from 2026 to 2035. The aesthetic injectable market is driven by the rising consumer preference for non-surgical cosmetic procedures that offer quick, natural-looking results with minimal downtime. - [Non-invasive Cancer Diagnostics Market](https://www.novaoneadvisor.com/report/non-invasive-cancer-diagnostics-market) - The non-invasive cancer diagnostics market size was estimated at USD 85.95 billion in 2025 and is projected to increase from USD 92.22 billion in 2026 to approximately USD 173.88 billion by 2035, growing at a CAGR of 7.3% from 2026 to 2035. The non-invasive cancer diagnostics market is driven by the escalating global incidence of cancer prevalence and aging demographics, integration of technological innovations and AI, and advancement in liquid biopsies. - [Companion Diagnostics Market](https://www.novaoneadvisor.com/report/companion-diagnostics-market) - The companion diagnostics market size was estimated at USD 10.25 billion in 2025 and is projected to increase from USD 11.28 billion in 2026 to approximately USD 26.80 billion by 2035, growing at a CAGR of 10.09% from 2026 to 2035. The companion diagnostics market is driven by the increasing shift toward precision medicine, rising cancer incidence, and pharmaceutical and diagnostic companies are increasingly collaborating to pair new therapies with diagnostic tests, which ensures faster regulatory approvals and long-term cost-effectiveness. - [Dental Bracket Market](https://www.novaoneadvisor.com/report/dental-bracket-market) - The dental bracket market size was estimated at USD 4.22 billion in 2025 and is projected to increase from USD 4.51 billion in 2026 to approximately USD 8.15 billion by 2035, growing at a CAGR of 6.8% from 2026 to 2035. The dental bracket market is driven by the rising demand for aesthetic dentistry, integration of 3D printing, AI-assisted imaging, and customized digital treatment planning, and the increasing prevalence of dental issues. - [U.S. Non-Invasive Cancer Diagnostics Market](https://www.novaoneadvisor.com/report/us-non-invasive-cancer-diagnostics-market) - The U.S. non-invasive cancer diagnostics market size was estimated at USD 27.55 billion in 2025 and is projected to increase from USD 29.64 billion in 2026 to approximately USD 57.31 billion by 2035, growing at a CAGR of 7.6% from 2026 to 2035. The U.S. non-invasive cancer diagnostics market is driven by the increasing cancer prevalence and aging demographics, innovation in artificial intelligence imaging and multi-omics, and growing government support and healthcare infrastructure. - [Diabetes Clinical Trials Market](https://www.novaoneadvisor.com/report/diabetes-clinical-trials-market) - The diabetes clinical trials market size was estimated at USD 5.35 billion in 2025 and is projected to increase from USD 5.73 billion in 2026 to approximately USD 10.63 billion by 2035, growing at a CAGR of 7.11% from 2026 to 2035. The diabetes clinical trials market is driven by the rising global diabetic population, expansion of GLP-1 and cardiometabolic drugs, and growing focus on precision medicine and significant funding for research and development. - [US Point-Of-Care Testing (POCT) Market](https://www.novaoneadvisor.com/report/us-point-of-care-testing-poct-market) - The US point-of-care testing (POCT) market size was estimated at USD 12.25 billion in 2025 and is projected to increase from USD 13.41 billion in 2026 to approximately USD 30.27 billion by 2035, growing at a CAGR of 9.47% from 2026 to 2035. The US point-of-care testing (POCT) market is driven by the rising burden of chronic and infectious diseases, integration of telehealth and digital health integration, and innovation in microfluidics, biosensors, and smartphone-integrated diagnostics platforms, making testing faster, more portable, and easier to use without extensive clinical training. - [U.S. Intrauterine Devices Market](https://www.novaoneadvisor.com/report/us-intrauterine-devices-market) - The U.S. intrauterine devices market size was exhibited at USD 2.55 billion in 2025 and is projected to hit around USD 6.71 billion by 2035, growing at a CAGR of 10.16% during the forecast period 2026 to 2035. - [U.S. Pupillometer Market ](https://www.novaoneadvisor.com/report/us-pupillometer-market) - The U.S. pupillometer market size was estimated at USD 114.25 million in 2025 and is expected to be worth around USD 202.68 million by 2035, poised to grow at a compound annual growth rate (CAGR) of 5.9% during the forecast period 2026 to 2035. - [U.S. Post-acute Care Market](https://www.novaoneadvisor.com/report/us-post-acute-care-market) - The U.S. post-acute care market size was exhibited at USD 461.38 billion in 2025 and is projected to hit around USD 766.71 billion by 2035, growing at a CAGR of 5.21% during the forecast period 2026 to 2035. - [U.S. Clinical Nutrition Market](https://www.novaoneadvisor.com/report/us-clinical-nutrition-market) - The U.S. clinical nutrition market size was exhibited at USD 15.75 billion in 2025 and is projected to hit around USD 34.35 billion by 2035, growing at a CAGR of 8.11% during the forecast period 2026 to 2035. - [U.S. Home Infusion Therapy Market](https://www.novaoneadvisor.com/report/us-home-infusion-therapy-market) - The U.S. home infusion therapy market size was valued at USD 22.55 billion in 2025 and is projected to surpass around USD 48.23 billion by 2035, registering a CAGR of 7.9% over the forecast period of 2026 to 2035. - [U.S. Ambulatory Surgery Center Market](https://www.novaoneadvisor.com/report/us-ambulatory-surgery-centers-market) - The U.S. ambulatory surgery center market size was estimated at USD 43.75 billion in 2025 and is projected to hit around USD 80.60 billion by 2035, growing at a CAGR of 6.3% during the forecast period from 2026 to 2035. - [U.S. Veterinary Surgical Instruments Market](https://www.novaoneadvisor.com/report/us-veterinary-surgical-instruments-market) - The U.S. veterinary surgical instruments market size was exhibited at USD 481.35 million in 2025 and is projected to hit around USD 792.32 million by 2035, growing at a CAGR of 5.11% during the forecast period 2026 to 2035. - [U.S. Trauma Fixation Devices Market](https://www.novaoneadvisor.com/report/us-trauma-fixation-devices-market) - The U.S. trauma fixation devices market size was exhibited at USD 6.45 billion in 2025 and is projected to hit around USD 8.58 billion by 2035, growing at a CAGR of 2.9% during the forecast period 2026 to 2035. - [U.S. Biomedical Refrigerators and Freezers Market](https://www.novaoneadvisor.com/report/Us-biomedical-refrigerators-freezers-market) - The U.S. biomedical refrigerators and freezers market size was exhibited at USD 1.85 billion in 2025 and is projected to hit around USD 3.07 billion by 2035, growing at a CAGR of 5.21% during the forecast period 2026 to 2035. - [U.S. Telemedicine Market](https://www.novaoneadvisor.com/report/us-telemedicine-market) - The U.S. telemedicine market size was exhibited at USD 41.54 billion in 2025 and is projected to hit around USD 188.05 billion by 2035, growing at a CAGR of 16.3% during the forecast period 2026 to 2035. - [U.S. Group 2 Powered Mobility Devices Market](https://www.novaoneadvisor.com/report/Us-group-2-powered-mobility-devices-market) - The U.S. group 2 powered mobility devices market size was exhibited at USD 3.95 billion in 2025 and is projected to hit around USD 12.38 billion by 2035, growing at a CAGR of 12.1% during the forecast period 2026 to 2035. - [U.S. Ophthalmic Sutures Market](https://www.novaoneadvisor.com/report/us-ophthalmic-sutures-market) - The U.S. ophthalmic sutures market size was exhibited at USD 356.35 million in 2025 and is projected to hit around USD 632.17 million by 2035, growing at a CAGR of 5.9% during the forecast period 2026 to 2035. - [Artificial Intelligence (AI) Software Market](https://www.novaoneadvisor.com/report/artificial-intelligence-software-market) - The global artificial intelligence (AI) software market size was exhibited at USD 209.35 billion in 2025 and is projected to hit around USD 1,657.96 billion by 2035, growing at a CAGR of 22.99% during the forecast period 2026 to 2035. - [Artificial Intelligence (AI) in Retail Market](https://www.novaoneadvisor.com/report/artificial-intelligence-in-retail-market) - The global artificial intelligence (AI) in retail market size was exhibited at USD 8.41 billion in 2025 and is projected to hit around USD 45.74 billion by 2035, growing at a CAGR of 18.45% during the forecast period 2026 to 2035. - [3D Printers Market](https://www.novaoneadvisor.com/report/3d-printers-market) - The global 3D printers market size was exhibited at USD 22.68 billion in 2025 and is projected to hit around USD 88.61 billion by 2035, growing at a CAGR of 17.54% during the forecast period 2026 to 2035. ## Company Nova One Advisor - Global Market Research, Industry Intelligence & Strategic Consulting Nova One Advisor is a full-service global market research and consulting firm delivering trusted market intelligence, industry forecasts, competitive analysis, market sizing, company profiling, technology assessments, strategic consulting, and customized research solutions across healthcare, life sciences, chemicals, advanced materials, energy, manufacturing, automotive, consumer goods, food & beverages, packaging, information technology, semiconductors, telecommunications, construction, aerospace, and numerous other global industries. Our research helps businesses, investors, consultants, and decision-makers identify growth opportunities, understand market dynamics, benchmark competitors, and make data-driven strategic decisions worldwide.